Work

Late Breaking Abstract - Depemokimab efficacy/safety in patients with asthma on medium/high-dose ICS: The Phase IIIA randomised SWIFT-1/2 studies

Year: 2024

Type: conference-abstract

DOI: 10.1183/13993003.congress-2024.rct3718

Authors: David J. Jackson, Michael E. Wechsler, Daniel J. Jackson, Stephanie Korn, David Bernstein, Paul E. Pfeffer, Gustavo De Luíz Martinez, Ruchong Chen, Junpei Saito, Loretta Jacques, Nicholas Bird, Stein Schalkwijk, Douglas Smith, Ian D. Pavord

Institutions: University of Wisconsin–Madison, King's College London, Guy's and St Thomas' NHS Foundation Trust, National Jewish Health, Bernstein Clinical Research Center, University of Cincinnati, Barts Health NHS Trust, First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, Fukushima Medical University, GlaxoSmithKline (United Kingdom), GlaxoSmithKline (United States), University of Oxford

Language: English

Topic: Asthma and respiratory diseases

Subfield: Physiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4404127320

Cites:

Cited by:

Related to: 10